BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21617236)

  • 1. Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in different molecular types of breast cancer.
    Raica M; Cimpean AM; Ceausu R; Ribatti D
    Anticancer Res; 2011 May; 31(5):1757-64. PubMed ID: 21617236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
    Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P
    Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
    Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K
    Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relation of lymphatic microvessel density detected by monoclonal antibody D2-40 with VEGF-C expression in breast cancer].
    Xie XD; Qu SX; Zheng ZD; Song FL; Liu DW
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):356-60. PubMed ID: 18953835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
    Lee AH; Dublin EA; Bobrow LG; Poulsom R
    J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic microvessels density, VEGF-C, and VEGFR-3 expression in 25 cases of breast invasive lobular carcinoma.
    Ciobanu M; Eremia IA; Crăiţoiu S; Mărgăritescu CL; Stepan A; Pătraşcu V; Georgescu CC; Cernea D; Dumitrescu D
    Rom J Morphol Embryol; 2013; 54(4):925-34. PubMed ID: 24398987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer.
    Schoppmann SF; Tamandl D; Roberts L; Jomrich G; Schoppmann A; Zwrtek R; Dubsky P; Gnant M; Jakesz R; Birner P
    Ann Oncol; 2010 May; 21(5):955-60. PubMed ID: 19940005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer.
    van Iterson V; Leidenius M; von Smitten K; Bono P; Heikkilä P
    Am J Clin Pathol; 2007 Nov; 128(5):759-66. PubMed ID: 17951197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
    Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site.
    van der Schaft DW; Pauwels P; Hulsmans S; Zimmermann M; van de Poll-Franse LV; Griffioen AW
    Cancer Lett; 2007 Aug; 254(1):128-36. PubMed ID: 17442484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma].
    Fan YZ; Li GM; Huang GP; Li XP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):477-82. PubMed ID: 17143789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
    Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
    Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphangiogenic characteristics of triple negativity in node-negative breast cancer.
    Liu HT; Ma R; Yang QF; Du G; Zhang CJ
    Int J Surg Pathol; 2009 Dec; 17(6):426-31. PubMed ID: 19493918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of vascular endothelial growth factor A and C in human breast cancer and their significance].
    Hu SE; Zhang YJ; Cui YM; Zhang HQ
    Ai Zheng; 2005 Sep; 24(9):1076-9. PubMed ID: 16159428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
    Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B
    J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer.
    Van den Eynden GG; Van der Auwera I; Van Laere SJ; Huygelen V; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    Br J Cancer; 2006 Nov; 95(10):1362-6. PubMed ID: 17088912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
    Mylona E; Alexandrou P; Mpakali A; Giannopoulou I; Liapis G; Markaki S; Keramopoulos A; Nakopoulou L
    Eur J Surg Oncol; 2007 Apr; 33(3):294-300. PubMed ID: 17129704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.